Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
16/07/2025
Zhejiang Zhenyuan expressed on the interactive platform that the innovative new drug used for cancer pain treatment is still in the exploratory research stage, and there is currently no plan for it to be launched on the market.
Latest
1 m ago
Market news: Boeing is one of the primary targets of the EU's retaliation plan against the United States.
2 m ago
Analyst: UK long-term bond yields may continue to rise.
3 m ago
Vice President of China Council for the Promotion of International Trade, Li Qingshuang attended the meeting of the Standing Committee of the SCO Business Council.
3 m ago
China Eastern Airlines Corporation Limited (00670.HK) repurchased 2.5 million shares for 7.2631 million Hong Kong dollars on July 16th.
3 m ago
Guangshengtang: The innovative drug GST-HG131 for the treatment of hepatitis B has been included in the list of breakthrough therapies by the drug evaluation center, but this does not mean that it will be approved for market launch.
See all latest